Checkpoint Therapeutics (CKPT) Stock Chart & Stock Price History $4.04 +0.01 (+0.25%) Closing price 04:00 PM EasternExtended Trading$4.04 0.00 (0.00%) As of 07:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Checkpoint Therapeutics Stock Price Performance 5 Day Performance-0.74%1 Month Performance+41.26%3 Month Performance+15.76%6 Month Performance+79.56%Year-To-Date Performance+26.25%1 Year Performance+97.07% Receive CKPT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Checkpoint Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address CKPT Stock Chart for Friday, March, 28, 2025 CKPT Chart by TradingViewRemove Ads Checkpoint Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization03/28/2025$4.03$4.04+0.25%$4.04$4.03522,554 shs$197.29 million03/27/2025$4.06$4.03-0.74%$4.06$4.031.14 million shs$196.80 million03/26/2025$4.06$4.06$4.07$4.05576,448 shs$198.26 million03/25/2025$4.05$4.06+0.25%$4.06$4.051.32 million shs$198.26 million03/24/2025$4.07$4.05-0.49%$4.06$4.05864,977 shs$197.77 million03/21/2025$4.06$4.07+0.25%$4.07$4.05980,428 shs$198.75 million03/20/2025$4.07$4.06-0.25%$4.06$4.03849,112 shs$198.26 million03/19/2025$4.01$4.07+1.50%$4.07$4.013.20 million shs$198.75 million03/18/2025$3.99$4.01+0.50%$4.02$3.982.95 million shs$195.82 million03/17/2025$3.97$3.99+0.50%$4.00$3.974.27 million shs$194.84 million Get the Latest News and Ratings for CKPT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Checkpoint Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 03/14/2025$3.99$3.97-0.50%$4.00$3.977.54 million shs$193.87 million03/13/2025$3.98$3.99+0.25%$4.00$3.985.65 million shs$194.84 million03/12/2025$4.00$3.98-0.50%$4.02$3.987.03 million shs$194.36 million03/11/2025$3.98$4.00+0.50%$4.03$3.9910.35 million shs$195.33 million03/10/2025$2.47$3.98+61.13%$4.08$3.9661.89 million shs$194.36 million03/07/2025$2.38$2.47+3.78%$2.52$2.37619,382 shs$120.62 million03/06/2025$2.49$2.38-4.42%$2.55$2.37883,167 shs$116.22 million03/05/2025$2.63$2.49-5.32%$2.63$2.43628,629 shs$121.59 million03/04/2025$2.57$2.63+2.33%$2.68$2.43668,213 shs$128.43 million03/03/2025$2.86$2.57-10.14%$2.86$2.53968,544 shs$125.50 million02/28/2025$2.71$2.86+5.54%$2.89$2.64799,519 shs$139.66 million02/27/2025$2.78$2.71-2.52%$2.89$2.71436,926 shs$132.34 million Related Companies uniQure Stock Chart AbCellera Biologics Stock Chart Chimerix Stock Chart Praxis Precision Medicines Stock Chart LENZ Therapeutics Stock Chart Bicara Therapeutics Stock Chart Cronos Group Stock Chart Prothena Stock Chart ArriVent BioPharma Stock Chart Organogenesis Stock Chart Receive CKPT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Checkpoint Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CKPT) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredNow that Trump’s be inaugurated, this day will be key (mark your calendar)Mark your calendar for May 7th. Because on that day, I believe we could see a $2 Trillion shock INTO the ma...Timothy Sykes | SponsoredDo this Before Elon's Reveal on April 23rdElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Checkpoint Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Checkpoint Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
